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MASS TREATMENT OF FILARIASIS 
IN,  SIDONDO, CENTRAL SULAWESI 
J. Putrali* and J.M. Caleb* 
Pengobatan massal terhadap penyakit Kaki Galah telall dilakukan pada penduduk desa Sidondo, 
Sulawesi Tengah dengan menggunakan obat Filarzan, (diethylcarbamazine citrate). 
Delapan puluh tiga per cent dari penduduk telah tercakzcp pada pengobatan ini dan delapan puluh 
sembilan per cent dari penderita yang rnengandung bibit penyakit ini dalam darahnya dapat disem- 
buhkan. 
Gejala-gejala samping ditemukan pada penderita dan reaksi dari pengobatan yang ditemukan diantara 
penduduk yang tidak melihatkan gejala 
The Palu valley of Central Sulawesi (Indo- 
nesia) is an endemic area for Brugia malayi- 
filariasis (Tesch, 1937). The vector is Arlopheles 
barbirostris (Brug, 1937). Surveys in' 1971 
(Sri Oemijati e t  al, unpublished) revealed a 
microfilaraemia (M.F.) rate ranging from 11 to 
31 per cent in several villages. The same 
survey indicated that the parasite was of the 
nocturnal periodic type. 
The present study was designed t o  provide 
guidelines for future treatment of fiiariasis in 
the entire valley. For this  purpose we selected 
Sidondo village, because it had the highest 
prevalence (31 per cent) of positive cases 
amongst those surveyed in 1971. 
MATERIALS AND METHODS 
Sidondo is located about the middle of 
Palu Valley, 10 t o  20  M. above sea level, with 
mean daily temperature about 30°C. Rainfall 
is approximately 500 mm. a year wit11 the 
rainy season occuring between .October and 
February. 
The study population consisted mostly of 
small farmers, who work on dry and wet 
fields around the village. Corn, tobacco, and 
coconuts are grown in addition t o  rice. Most 
of the inhabitants are Kailiers, autochtonous 
inhabitants of Palu valley, but included are 
some Buginese families from South Sulawesi. 
The study was conducted in two steps : 
Survey I and mass treatment, July 1972 
Survey I1 evalution, October 1972. 
* Provincial Health Service of Central Sulawesi. Palu, 
Survey 1 and mass treatment was by a team 
of 10 persons headed by physician who stayed 
in the village 10 days. They mapped the area, 
numbered the houses and conducted a census. 
There are 1970 pet~ple and 299 houses in the 
village. Ninety-nine families were selected at  
random and asked to come t o  the medical 
post for bleeding. Finger blood was taken 
after 7.30 p.m. with a 20  cubic millimeter 
pipet. Thick smears were made and stained 
with Giemsa the next morning. Filarzan 
(diethyl carbamazine citrate) tablets were given 
with a total dose of 3 0  mg per kg body weight: 
5 mg/kg body weight for six consecutive days. 
Patients came to the post six times. Each day 
after receiving Filarzan, which was ingested in 
our presence, they were asked about side- 
effects. Home visits were arranged for those 
unable to  come to the post. Some individuals 
from outside the sample group also came to 
the post. They were not bled but received 
the same dose of Filatzan as those in the 
sample. 
Survey I1 was held by the same team, and 
83 families selected a t  random for study. Blood 
examinations were done as in survey I, i n d  
n1.f. positive persons found in survey 1 were 
re-examined. 
RESULTS 
In  Sidondo, 1502 of the 1970 (83.9 per 
cent) inhabitants were treated. Of these, in 
the first survey 514 (28.7 per cent) were 
- examined, and 388 (21.7 per cent) were 
examined in survey 11. 
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Table 1. Microfilaraernia by age and sex before treatment. 
T O T A L  M A  L  E F E M A L E  Age Group 
(Years) N ~ ,  N ~ .  pos Percent N O . E X ~ .  NO. Pos P ~ ~ , " n t  No.Exd. No. Pos 
Pos 
TOTAL 
Table I gives microfilaraemia distributions 
by age and sex in survey I. The M.F. rate is 
lowest in age group 1 - 6 (11.5 per cent), is 
higher in the following 2;- groups and reaches 
a maximum in the 31 - 38 age group (38 per 
cent). 
In those above 49, the rate was only 28 per 
cent. The m.f. rate for males was 30.8 per 
cent, in females 26.2 per cant, and the overall 
rate 28.5 per cent. The youngest m.f. positive 
persons were a two year old boy and girl. 
The oldest was a 77 year old man. The highest 
m.f. count was 165 per 20 cubic millimeter. 
Ninety of 147 m.f. positive persons had counts 
of 1 - 10. 
Fifteen hundred and two persons were 
treated in Sidondo, a coverage of 83.9 per 
cent. in this mass treatment, an average of 22% 
Filarzan tablets, used per person, (100 mg. 
per tablet) were for a total of 33804. Two 
hundred eighty-eight persons were not treated: 
60 were pregnant, 77 were infants, 21 were 
elderly, 59 were sick, 5 refused treatment, and 
in. 66 cases the reasons for non-treatment is 
unknown. 
Table 2 gives microfilaraemia distributions 
by age and sex in survey 11. 
The highest m.f. rate was in age group 19 - 24. 
The rate in males was 4.5 per cent, in females 
4.2 per cent. The total m.f. rate was 4.3 per 
cent. The youngest m.f. positive was boy 
aged 5 years, and the oldest a man aged 35. 
(There were 147 m.f. positive persons in survey 
I before treatment. Were-examined 140 aftel 
Table 2. Microfilaraernia by age and sex after treatment. 
T O T A L  M A L E  F E M A L E  
Age Group 
(Years) N O . E X ~ .  NO. ~ o s  P"p',":nt N O . E X ~ .  NO. Pos 'epbcsent No.Exd. NO. Pos PT,","nt 
TOTAL 388 17 4,3 198 9 4,5 190 8 4.2 
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Table 3. Summary of mass treatment results. 
BEFORE TREATMENT THREE MONTHS AFTER TREATMENT 
Total m.f. Average M.F count Total m.f. ,Average m.f count 
No. Exd. No. Pos. Percent ~n 20 cu mrn blood/ No. Exd. No. Pos. Percent 
count ~n 20 cu mm blood1 count Pos Total Pos Total 
Fig. I. Trial by age group and microfilaria rate in Table 4. Individuals still m.f. positive after Sidondo, October 1972. treatment. 
Perceni MF - Pos.Pers 1 13 Before Rx ,  After R x  
treatment, and found 125 negative, for a cure 
rate of 89 per cent). Fifteen persons were still 
infected after treatment (treatment failures), as 
shown in Table 4. 
Table 5 lists side-effects of the treatment 
in  m.f. positive and negative persons. 
Table 3 summarizes results of our trial. 
The m.f. rate was lowered from 28.9 to  4.38 
and the average m.f. count per positive de- 
creased from 20 to 4.6. The result of trial 
by age-group and microfilaria rate was shown 
in figure I. 
bide-effects and the m.f. count were also 
compared. In m.f. positive persons, 41 per 
cent developed fever, while in the negative 
group only 18 per cent became febrile. The 
m.f. count group 11 - 25 had the most side- 
<ffects. Shock was a side-effect but it was not 
found in this study. 
DISCUSSION 
Mass treatment with 5 mg/kg body weight 
of Filarzan on 6 consecutive days seemed 
M.F. count M.F. count 
No. Sex Age Before treatment After treatment 
Table 5. Side effects from Filarzan. 
A. M.F. Positive (147 
1. Fever 
2. Vomiting 
3. Dizziness 
4. Abdominal pains 
5. Lymphadenitis 
6. Lymphangitis 
treated) 
No. 
61 
22 
18 
16 
9 
4 
B. M.F. Negative (367 treated) 
No. 
1. Fever 67 
2. Abdominal pains 11 
3. Vomiting 8 
4. Dizziness 8 
5. Lymphadenitis 5 
6. Lymphangitis 3 
Per cent 
4 1 
15 
1-2 
11 
6 
3 
Per cent 
18 
3 
2 
2 
1 
0.8 
successful. Most of the population was reached, 
and the decrease in persons with microfila- 
rnernia was dramatic (28.9 to 4.4 per cent). 
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Table 6. M.F. counts and side effects. 
Fever Lvm~hadenit is  Vomitina 
. . 
M.F. Count No .  Treated Per- Per- Per- 
Nu. cent No. cent cent 
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Comparable results were obtained by Harinasu- 
ta et a1 (1970) in Thailand. who used diethyl 
carbamazine, 5 mg/kg once weekly for 6 weeks. 
and lowered m.f. positive rates from 21.2 to 
2.2 per cent. Cure rate in this study was 89 
per cent, and treatment on successive days 
more practical in our campaign. 
Fever and vomiting were the dominant side- 
effects in this trial. Localized side-effects such 
as lymphadenitis were uncommon. Infected 
persons had mode side-effects than m.f. nega- 
tive persons, however, those with higher m.f. 
counts did not necessarily have more side- 
effects (Table 6). 
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